Glucose control in intensive care: usability, efficacy and safety of Space GlucoseControl in two medical European intensive care units

Table 1 Demographic and clinical characteristis of the study population in Zurich (n = 20)

Demographic characteristics
Male (n/%)	13 (65%)
Age (yrs)	60.2 ± 14.3
Body mass index (kg/m²)	29.0 ± 6.6
APACHE II	24.2 ± 4.5
Clinical characteristics (n)
Admission diagnosis	Post cardiac arrest (4)
	Sepsis (3)
	Pulmonary (3)
	Cardiac (5)
	Neurologic (1)
	Other (4)
Mechanically ventilated	17 (85%)
Vasopressor therapy	Norepinephrine: 11 (55%) Dobutamine: 4 (20%)
Renal replacement therapy	4 (20%)
Steroid treatment	6 (30%)
Parenteral nutrition	6 (30%)
Enteral nutrition	18 (90%)
History of diabetes	4 (20%)
Patients on insulin before study start	18 (90%)
Hospital mortality	6 (30%)

Data are given as numbers (n) or means ± SD as appropriate. Baseline data of the study population in Graz have been reported previously [28]. There are no significant differences between both populations with the exception of a higher rate of norepinephrine use (90 vs. 55%, P < 0.01) and a higher rate of parenteral nutrition in Graz 85 vs. 30%, P < 0.01.

ISSN: 1472-6823